BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma YS, Wang XF, Yu F, Wu TM, Liu JB, Zhang YJ, Xia Q, Jiang ZY, Lin QL, Fu D. Inhibition of USP14 and UCH37 deubiquitinating activity by b-AP15 as a potential therapy for tumors with p53 deficiency. Signal Transduct Target Ther 2020;5:30. [PMID: 32296042 DOI: 10.1038/s41392-020-0143-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu M, Wang W, Wang J, Fang C, Liu T. Z-Guggulsterone alleviates renal fibrosis by mitigating G2/M cycle arrest through Klotho/p53 signaling. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.109846] [Reference Citation Analysis]
2 Chen X, Dou QP, Liu J, Tang D. Targeting Ubiquitin-Proteasome System With Copper Complexes for Cancer Therapy. Front Mol Biosci 2021;8:649151. [PMID: 33928122 DOI: 10.3389/fmolb.2021.649151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tyagi A, Haq S, Ramakrishna S. Redox regulation of DUBs and its therapeutic implications in cancer. Redox Biol 2021;48:102194. [PMID: 34814083 DOI: 10.1016/j.redox.2021.102194] [Reference Citation Analysis]
4 Park J, Cho J, Song EJ. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment. Arch Pharm Res 2020;43:1144-61. [PMID: 33165832 DOI: 10.1007/s12272-020-01281-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
5 Ma YS, Chu KJ, Ling CC, Wu TM, Zhu XC, Liu JB, Yu F, Li ZZ, Wang JH, Gao QX, Yi B, Wang HM, Gu LP, Li L, Tian LL, Shi Y, Jiang XQ, Fu D, Zhang XW. Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis. Mol Ther Nucleic Acids 2020;21:229-41. [PMID: 32585630 DOI: 10.1016/j.omtn.2020.05.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
6 Tian T, McLean JW, Wilson JA, Wilson SM. Examination of genetic and pharmacological tools to study the proteasomal deubiquitinating enzyme ubiquitin-specific protease 14 in the nervous system. J Neurochem 2021;156:309-23. [PMID: 32901953 DOI: 10.1111/jnc.15180] [Reference Citation Analysis]
7 Tian LL, Qian B, Jiang XH, Liu YS, Chen T, Jia CY, Zhou YL, Liu JB, Ma YS, Fu D, Ding ST. MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients. Int J Genomics 2021;2021:6670390. [PMID: 33816607 DOI: 10.1155/2021/6670390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lv C, Wang S, Lin L, Wang C, Zeng K, Meng Y, Sun G, Wei S, Liu Y, Zhao Y. USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma. Cell Death Dis 2021;12:803. [PMID: 34420039 DOI: 10.1038/s41419-021-04089-6] [Reference Citation Analysis]
9 Zhang DD, Shi Y, Liu JB, Yang XL, Xin R, Wang HM, Wang PY, Jia CY, Zhang WJ, Ma YS, Fu D. Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma. Mol Ther Nucleic Acids 2021;24:1033-50. [PMID: 34141458 DOI: 10.1016/j.omtn.2021.04.019] [Reference Citation Analysis]